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Retinal pigment epithelium (RPE) is an epithelial cell monolayer located in the retina region 
at the back of the eye. RPE has a significant function in the eyesight as it plays a key role in 
the supporting of photoreceptor functions. Disorders of RPE lead to degenerative eye dis-
eases – such as macular degeneration and retinitis pigmentosa – that are the leading causes 
of blindness. In the future, these blinding retinal disorders could potentially be cured by uti-
lizing regenerative medicine. Degenerated RPE could be replaced by tissue graft derived 
from human pluripotent stem cells (hPSC). 
 
Currently, the differentiation of hPSCs to RPE cells is inefficient and results in low yields of 
functional cells. The yield of differentiated cells could be improved for example by chemical 
induction of the cells. The objective of the thesis was to further optimize a directed RPE 
differentiation method. In the future, more effective ways to produce hPSC-RPE could be 
used to develop tissue grafts that can be utilized in regenerative medicine.  
 
The aim of the study was to compare adherent and embryoid body (EB)-like culture meth-
ods for directed differentiation of hPSCs into RPE. The comparison was done by evaluating 
the formation of melanin pigmentation between different culture methods and by analyzing 
the quality of the produced cells. The hPSCs used in this thesis were human embryonic stem 
cells (hESC) and induced pluripotent stem cells (iPSC). Differentiation was directed by a 
use of growth factor and small molecule induction. 
 
Cells produced in this study were analyzed by morphology, transepithelial resistance (TER) 
and immunocytochemical stainings focusing on RPE markers. The characterization methods 
provided information about the differentiation status of the cells, including morphology, 
tightness of the cell junctions, protein expression and polarization of the cell monolayer. 
 
The results suggest that for this protocol of directed differentiation of hPSCs into RPE, the 
adherent culture method gives significantly better yield than the EB-like culture method. 
The induction seemed to work with both hESCs and iPSCs, but the yield tended to differ 
between the stem cell types, favoring the differentiation of hESC-RPE cells.  The cell cul-
tures on porous Polyethylene Terephthalate (PET) membrane did not form a confluent cell 
monolayer, and further research is needed on the reasons behind this behavior. However, the 
immunostainings suggested that the quality of hESC-RPE was desirable despite the relative-
ly young age of the differentiated cells. 
   
Key words: human pluripotent stem cell, adherent cell culture, embryoid body, RPE, 
differentiation 
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Verkkokalvon pigmenttiepiteeli (RPE) on retinassa sijaitseva yksikerroksinen solukerros, 
jolla on useita tehtäviä verkkokalvon valoaistinsolujen ylläpidossa. Monet sokeuteen 
johtavat sairaudet, kuten verkkokalvon ikärappeuma ja pigmenttidegeneraatio, ovat 
seurausta RPE-solujen vaurioitumisesta. Kantasolujen hyödyntämistä kudosteknologisissa 
sovelluksissa pidetään lupaavana tulevaisuuden hoitokeinona verkkokalvon vaurioiden 
hoidossa. Laboratorio-olosuhteissa voidaan tuottaa kaikkikykyisistä kantasoluista 
kasvatettuja siirteitä, joilla on mahdollista korvata vaurioituneita alueita.  
 
Nykyisin yleisesti käytetyt RPE-solujen erilaistusmenetelmät ovat suhteellisen tehottomia, 
sillä erilaistuksella tuotettujen solujen saannot ovat pieniä. Opinnäytetyön tavoitteena oli 
selvittää adherentin ja suspensioviljelymenetelmien eroavaisuuksia erilaistettaessa 
kaikkikykyisistä kantasoluista RPE-soluja. Erilaistusmenetelmien kehittyessä kantasoluista 
voidaan tuottaa RPE-soluja, joita on mahdollista hyödyntää kudosteknologisissa 
sovelluksissa. 
 
Opinnäytetyön tarkoituksena oli vertailla adherenttia ja suspensioviljelymenetelmää ihmisen 
kaikkikykyisten kantasolujen suunnatussa erilaistuksessa. Työn tutkittavina kaikkikykyisinä 
eli pluripotentteina kantasoluina käytettiin ihmisen alkion kantasoluja sekä indusoituja 
pluripotentteja kantasoluja. RPE-tyyppisten solujen erilaistumista seurattiin visuaalisesti 
solujen tuottaman melaniinipigmentin avulla. Erilaistusmenetelmiä vertailtiin 
tarkastelemalla tuotettujen RPE-solujen määrää ja laatua. Soluja karakterisoitiin 
transepiteelisen resistanssin ja immunosytokemiallisten värjäyksien perusteella. 
Karakterisointimenetelmät määrittivät epiteelin solujen konfluenssia, solujen välisten 
liitosten tiiviyttä sekä solujen morfologiaa, polarisoitumista ja erilaistumisastetta.  
 
Erilaistusmenetelmistä adherentti soluviljelymenetelmä tuotti huomattavasti parempia 
tuloksia. Suunnattu erilaistus tuotti pigmentoituneita soluja sekä alkion kantasoluilla että 
indusoiduilla pluripotenteilla kantasoluilla, mutta vain alkion kantasoluista saatiin tuotettua 
tarpeeksi soluja jatkotutkimuksiin. Erilaistetut solut eivät muodostaneet kaikilla 
viljelyalustoilla RPE-soluille tyypillistä yksikerroksista epiteelisolukerrosta, ja syitä tämän 
käytöksen taustalla tulisikin tutkia tarkemmin. Solut olivat kuitenkin immunovärjäysten 
perusteella erilaistuksen kestoon nähden melko kypsiä RPE-tyyppisiä soluja. 
 
 
 
 
 
  
Asiasanat: ihmisen kaikkikykyiset kantasolut, adherentti soluviljelmä, embryoid body, 
RPE, erilaistus 
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ABBREVIATIONS 
 
 
AMD Age-related macular degeneration 
bFGF or FGF (Basic) fibroblast growth factor   
BM Bruch’s membrane 
BMP Bone morphogenetic protein  
BMSC Bone marrow stromal cell 
BSA Bovine serum albumin 
BVMD Best vitelliform macular dystrophy (Best’s disease)  
c-Myc Regulator gene that codes for a transcription factor.  
CRALBP Cellular retinaldehyde-binding protein 
DAPI 4 ́, 6 ́ diamidino-2-phenylindole  
DM- Basic culturing medium based on DMEM 
DM+ DM- medium with added growth factor and small molecule 
selective inhibitors 
DPBS or PBS (Dulbecco’s) phosphate buffer saline 
EB Embryoid body 
ECM Extracellular matrix 
EMT Epithelial-mesenchymal transition  
GLP Good laboratory practice  
hESC or ESC (Human) embryonic stem cell 
hiPSC or iPSC (Human) induced pluripotent stem cell 
hFF Human foreskin fibroblasts  
HSC Hemopoietic st em cell 
IF Immunofluorescence 
IVF  in vitro fertilization 
IWP-2 N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-
phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide 
JAM Junctional adhesion molecules  
Klf4 Kruppel-like factor 4 
KO-DMEM Knockout Dulbecco’s Modified Eagle Medium 
KO-SR Knockout Serum Replacement 
MAPC Multipotent adult progenitor cell 
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OCT4 Octamer-binding transcription factor 
PET Polyethylene Terephthalate 
POS Photoreceptor outer segment 
RP Retinitis pigmentosa  
RT Room temperature 
RPE Retinal pigment epithelium 
RPE65 Retinal pigment epithelium-specific 65 kDa protein 
SB-505124  2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-
methylpyridine hydrochloride 
SCED Single cell enzymatic dissociation  
SCNT  Somatic cell nuclear transfer 
STAP  Stimulus-triggered acquisition of pluripotency 
OX2 Transcription factor orexin-2 
TGF Transforming growth factors 
TER Transepithelial electric resistance  
ZO-1 Zonula occludens protein 1 
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1 INTRODUCTION 
 
Retinal pigment epithelium (RPE) is an epithelial cell monolayer located in the retina region 
at the back of the eye. The RPE has many vital functions in the eye, including transepithelial 
transport and regulation of biomolecules, taking part in the visual cycle and phagocytosis of 
the photoreceptors shed outer segments. Because of this critical role of the RPE, the 
degeneration of RPE leads to eye diseases such as age-related macular degeneration or 
retinis pigmentosa. Damages caused by retinal degeneration are currently the leading causes 
of permanent blindness (Strauss 2005). 
 
Currently, there are no effective widely accepted treatments to these drastic blinding 
diseases. It has been suggested that in the future, regenerative medicine could be the answer 
through RPE-cell tissue graft replacements. The functional RPE cells for these grafts can be 
differentiated from human pluripotent stem cells (hPSC). RPE-like cells can be derived from 
pluripotent stem cells spontaneously, but the yield could be improved through directed 
differentiation.  
 
This bachelor’s thesis was carried out in the Ophthalmology research group in the Institute 
of Biomedical Technology at the University of Tampere. The group is led by Academy of 
Finland Research Fellow Heli Skottman, PhD, and this thesis was supervised by PhD Tanja 
Ilmarinen. The main research aim for the group is to develop stem cell based tissue 
engineering applications for the retinal and corneal repair through cell transplantation and 
ophthalmic in vitro tissue models. 
 
This thesis took part in one of research group’s ongoing projects to develop more effective 
ways to differentiate RPE cells from hPSCs. The hPSCs used in this study were embryonic 
pluripotent stem cells (ESC) and induced pluripotent stem cells (iPSC). Objective was to 
derive hPSC-RPE cells with different differentiation conditions and to compare the 
differentiation efficiency and the quality of the produced cells. To enhance the 
differentiation efficiency, differentiation to RPE-like cells was directed by an induction 
method developed within the research group.  
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2 LITERATURE REVIEW 
 
 
2.1 Stem cells 
Stem cells are unspecialized cells capable of renewing themselves through cell division and 
they have potential to develop into many different cell types in the body. When a stem cell 
divides, each new cell can either remain as a stem cell or under certain physiologic or 
experimental conditions, they can be induced to become another type of tissue- or organ-
specific cell with special functions (Kolios & Moodley 2013). Stem cells are classified into 
different categories depending on the differentiation capacity; totipotent, pluripotent, 
multipotent, oligopotent or unipotent stem cells.  
Totipotent stem cells have the ability to differentiate to any type of cell in an organism. 
Zygotes or 2-3 days old embryos (morulas) are considered as totipotent cells. Pluripotent 
stem cells (PSC) have the ability to differentiate to any type of cell of the three germ layers, 
but cannot form even in favorable conditions a whole organ or individual since they lack the 
ability to form extraembryonic tissue. The embryonic stem cells (ESC) can be obtained from 
4-7 day old embryos (blastocysts) or they can be induced from somatic cells (induced 
pluripotent stem cells, iPSC). (Kolios & Moodley 2013.) 
Multipotent stem cells, or progenitor cells, are type of stem cells that are more differentiated 
and therefore less plastic.  They can form different cell types within certain tissue type, and 
for example multipotent hematocyte can differentiate to platelets (thrombocytes) or red or 
white blood cells (erythrocytes and leukocytes, respectively.) Oligopotent cells are 
considered tissue-resident progenitor cells with the potency to form a limited number of 
terminally differentiated cells, and are similar in a way to unipotent stem cells, such as germ 
cells, that are capable to form only one type of cell (Kolios & Moodley 2013). 
 
Given their unique regenerative abilities, stem cells offer new potentials for treating diseases 
which are caused by failure of certain tissue type, such as retinal degeneration, diabetes and 
heart diseases. Much work remains still to be done to understand how to use these cells for 
cell-based therapies to treat diseases.   
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2.1.1 Adult stem cells 
 
Many tissues contain reservoirs of stem cells called adult stem cells. Compared with ESCs, 
adult stem cells cannot differentiate into multiple lineages. As multipotent stem cells, adult 
stem cells are usually capable of differentiating only into lineage-specific cells. Adult stem 
cells residing in specific tissues and organs are called tissue specific stem cells.  
 
Bone marrow, for example, represents a unique reservoir of tissue specific stem cells. Bone 
marrow contains at least two other populations of stem cells; bone marrow stromal cells 
(BMSCs) and a heterogenous population of multipotent adult progenitor cells (MAPCs) 
such as mesenchymal stem cells, which appear to have broad developmental capabilities. 
MAPCs have the potential to differentiate to lineages of mesenchymal tissues, including 
bone, cartilage, fat, tendon, muscle, and marrow stroma. (Ross & Pawlina 2011.) 
 
When injected into an early blastocyst in vitro, single MAPCs contribute to most, if not all, 
somatic cell types. On transplantation, MAPCs engraft and differentiate to the hematopoietic 
lineage, in addition to the epithelium of liver, lung and gut. As MAPCs proliferate 
extensively without obvious senescence or loss of differentiation potential, they could be 
one ideal cell source for therapy of inherited or degenerative diseases (Kolios & Moodley 
2013.) 
 
 
2.1.2 Human embryonic stem cells 
Embryonic stem cells are undifferentiated pluripotent cells derived from the blastocyst stage 
embryos. Method to derive embryonic stem cells was first established with mouse 
embryonic stem cells (Evans & Kaufman, 1981) before the derivation of human embryonic 
stem cell (hESC) lines (Thomson et al. 1998). Embryonic stem cells form an ESC-line 
when they have been cultured under in vitro conditions and have been capable of dividing 
without differentiating for a prolonged period, usually months containing tens of passages 
(Kolios & Moodley 2013.) 
In Finland, the hESC lines are derived from surplus embryos from in vitro fertilization (IVF) 
clinics by the permission from the donors with no financial compensation made for the 
donation. (Skottman, 2010). Cells of the embryo’s inner cell mass are separated from the 
11 
 
 
 
outer cell mass and are placed on a layer of mitotically inactivated fibroblasts, commonly 
referred to as a feeder cell layer, or on a matrix which supports the pluripotency of the cells. 
The resulting cell population is expanded in vitro by subculturing the undifferentiated cells 
as colonies (Hoffman & Carpenter 2005; Kolios & Moodley 2013.)  
 
2.1.3 Induced pluripotent stem cells  
 
Induced pluripotent stem cells are stem cells that have been reprogrammed to pluripotent 
state from somatic cells. Currently, iPSCs can be generated with two notable methods; 
nuclear transfer from differentiated somatic cell to oocyte (i.e. egg cell) or by introducing a 
set of defined factors into somatic cells. 
 
Nuclear transfer – or somatic cell nuclear transfer (SCNT) – to oocytes is used in both 
reproductive and therapeutic cloning, resulting a viable embryo. The first successful nuclear 
transfer was used when the first cloned mammal Dolly the Sheep was created. However, 
SCNT is considered as inefficient method, since the stress placed on both the oocyte and the 
introduced nucleus are exceptional (Lomax & Dewitt 2013). 
 
Shinya Yamanaka and his research group introduced in 2007 a method to induce somatic 
cells to their pluripotent state by the introduction of four key transcription factors, OCT3/4, 
SOX2, Klf4, and c-Myc, which have since been referred as the Yamanaka factors. The first 
reprogramming of somatic cells was done with fibroblast from mouse (Takahashi 2006) and 
followed by generating iPSCs from human adult fibroblasts (Takahashi 2007). This research 
was remarkable in the field of stem cells, and Yamanaka and his fellow stem cell researcher 
John Gurdon were awarded the Nobel Prize for Physiology or Medicine in 2012 (The Nobel 
Assembly at Karolinska Institutet 2012.)   
 
Other combinations of transcription factors have also been employed in different studies, 
including the use of 1-4 factors in most cases (Stadtfeld & Hochedlinger 2010.) Some viral 
vectors used in introduction of the transcription factors, such as retroviruses and plasmids, 
may cause a genomic alteration to the host cells. Fortunately, nonintegrative reprogramming 
alternatives, such as Sendai virus, directed mRNA and protein transduction, have been 
discovered (Carr et al. 2013).  
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2.1.4 Stem cells in regenerative medicine 
 
Regenerative medicine and treatments based on stem cells seem to hold many promises for 
numerous applications in the future. The treatments are carried out with cells differentiated 
from the stem cells. Use of adult stem cells does not cause immune reaction when patients 
own autogeneic stem cells are used. However, since adult stem cells are already somewhat 
differentiated cells, they do not have the same differentiation potential as hPSCs. In the use 
of hPSCs, ethical issues are raised considering the use of hESCs, as derivation of hESC-
lines results in destruction of living blastocysts. Using the iPSCs in regenerative medicine 
can possibly overcome the ethical controversy of hESCs. Treatments done with allogeneic 
iPSC could potentially also be conducted without immunogenecity issues (Takahashi et al. 
2007; Yamanaka 2007). 
 
However, in 2011 a research by Zhao et al. claimed that cells differentiated from ESCs 
derived from inbred mice line could efficiently form teratomas within the same line 
individuals without any evident immune rejection. A teratoma is a type of tumor that may 
contain several tissue derivatives from more than one germ layer. When used allogeneic 
ESCs in the differentiation, teratomas did not appear due to rapid rejection of the cells by 
recipients. The same study also suggested that when using iPSCs derived with both 
retroviral and novel episomal approach, not did the mice only form teratomas but they also 
triggered an immune response, a body’s immunologic reaction to an antigen, despite being 
derived from autonomous somatic cells. The results raised concerns about the safety of the 
future regenerative medicine treatments (Zhao et al. 2011).  
 
The results provided by Zhao et al. (2011) have since been put on question, since it has been 
shown that in mouse (Araki et al. 2012,) rats (Kanemura et al. 2014) and monkey studies 
(Kamao et al. 2014) that cells differentiated from iPSCs were unlikely to cause tumors or 
immunogenicity. Since then, studies that utilize both ESC (Schwartz et al. 2014) and iPSC 
(Cyranoski 2014a) have advanced to clinical trials. For adult stem cells, currently only one 
widely used stem cell therapy treatment has been established. The treatment is provided with 
hematopoietic stem cells that are used mainly in bone-marrow transplants for cancer patients 
(Burt et al. 2008). 
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2.2 Stem cell culture and differentiation 
 
 
2.2.1 Pluripotent stem cell culture 
 
Native stem cells grow in complex environment and thus they tend to also have demanding 
in vitro culturing conditions. To keep the stem cell lines in undifferentiated state, some 
necessities have to be taken care of. Other type of cells, called feeder cells, can be co-
cultured with stem cell colonies in the same culturing well or a petri dish (Stacey et al., 
2006). The role of feeder cells is to secrete various growth factors and extracellular matrix 
(ECM) proteins that are beneficial by yet unclear ways for the growth and pluripotency of 
the stem cells (Hongisto et al. 2011.)  
 
In order to keep the conditions free from animal-derived materials which could be harmful 
in clinical applications, use of human fibroblasts, like commercially available neonatal 
human foreskin fibroblasts (hFF), is to be considered (Skottman 2010; Vaajasaari 2011). As 
in any other cell cultures, aseptic work, sterile instruments and right conditions are important 
for stem cell culturing. 
 
 
2.2.2 Differentiation in suspension culture 
 
Methods for stem cell differentiation are diverse, and several protocols can be used for the 
differentiation of same target cells. When hPSCs colonies are dissected and transferred to a 
suspension culture with medium with low basic fibroblast growth factor (bFGF) 
concentrations, the cells tend to form three-dimensional cell aggregates, called embryoid 
bodies (EB). EB formation resembles embryonic development (Carr et al. 2013.) Cell 
aggregates are formed from multiple cells and EB-culturing is not to be confused with single 
cell suspension culturing.  
 
EB-culturing makes the cells epithelioid tissue; similar to epithelium but they lack basement 
membrane where to adhere (Ross & Pawlina 2011.) In contrast to adherent cell cultures, EB 
cultures enable larger yields of cells, since free floating aggregates can distribute to the 
surrounding medium. Over time, the hPSCs cell aggregates start to spontaneously 
differentiate into cell types of all three germ layers (Klimanskaya 2006.) 
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2.2.3 Differentiation in adherent cell culture 
 
In adherent cell culture the cells attach to a surface and adhere to it, and depending from cell 
type, can form a confluent layer of cells. Because of this, the maturity and differentiation 
stage of the cells is easier to evaluate in adherent cell cultures than in suspension culture. 
 
Usually for cells to adhere, the surface has to be treated somehow, since in the native 
conditions cells adhere to extracellular matrix. ECM content differs from the origin of tissue, 
but constitutes mostly from specific proteins of proteoglycans, polysaccharides or fibers, 
such as collagen or laminin in basal lamina called Bruch’s membrane (Ross & Pawlina 
2011.) 
 
 
2.3 Structure of the eye  
 
The eye is a complex sphere-shaped sensory organ that has a lens system reminiscent of a 
camera. The act of seeing starts when the lens of the eye focuses light reflected from objects 
onto a light-sensitive membrane at the back of the eye, called the retina, where almost 70% 
of body’s sense cells are located. These sense cells send the information to the brain along 
the optic nerve and the brain processes the information that is contained in the visible light 
(Haug et al. 1999.)   
 
The wall of human eye consists of three separate layers, called sclera, choroid and retina, 
that all have different errands in the general functionality of the eye, presented in figure 1. 
The outer layer, sclera, serves as the eye’s protective outer coat. Sclera is attached to the eye 
socket by six small muscles that enable the movement of eyeball. Sclera transforms from 
white, opaque tissue to transparent cornea in the frontal part of the eye. All the light that 
enters in the eye goes through refracting cornea and thus cornea’s condition is highly 
important for maintaining a good vision. After passing through the cornea, light travels 
through ring-shaped pupil that manipulates the amount of light that enters in the retina.  
Pupil is attached to iris that is a colored, circular structure. Iris is responsible for controlling 
the diameter and size of the pupil depending of the intensity of the entering light. Behind the 
iris is located the lens that focuses the entering light in the retina by changing its shape (Ross 
& Pawlina 2011.) 
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The middle layer of the eye located next to the sclera is known as choroid. The choroid is a 
layer of blood vessels that is responsible for the nutrient transportation to retina. Between 
the iris and the choroid lays the ciliary body. Ciliary body contains smooth muscle fibers 
that change the shape of the lens and produces the transparent liquid (aqueous humor) that 
fills the front of the eye. Retina, the inner layer of the eye, consist of two main layers, the 
neural layer and retinal pigment epithelium (RPE) layer. The space between the lens and the 
retina is filled with gel called vitreous humor (Ross & Pawlina 2011.) Retina region is 
illustrated with the layers of the eye in the figure 1. 
 
 
 
FIGURE 1. Gross anatomy of the eye and retina (modified from Ross & Pawlina, 2011) 
 
 
2.3.1 Neural retina 
 
Despite its location, the neural portion of the eye is actually part of the central nervous 
system. The retina, light sensitive layer of tissue, has a complex neural circuitry that 
converts the photoreceptors’ electrical activity into action potentials that travel to the brain 
by axons in the optic nerve. (Purves et al. 2001) The retina consists of two main layers; 
neural retina and RPE. The RPE layer is described separately in more detail in following 
chapters. 
 
Neural retina is the most inner part of retina and is formed of seven layers of different cells 
as seen in figure 1. There are five types of neurons in the retina: photoreceptors, horizontal 
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cells, bipolar cells, amacrine cells and ganglion cells. Two main types of light-sensitive pho-
photoreceptors in the retina are called rods and cones. Rods provide black-and-white vision 
and function mainly in dim light, while cones function best in relatively bright light and are 
responsible for color vision (Purves et al. 2001.) Horizontal cells’ function is to help 
integrate and regulate the input from multiple photoreceptor cells. Bipolar cells transmit the 
signals from either one type of photoreceptor or horizontal cells on to the ganglion cells 
directly or indirectly by amacrine cells and retinal ganglion cells collectively transmit 
signals onwards to several regions in the brain. In neural retina, there are located glial cells 
called Müller cells. Müller cells form architectural support structures that stretch radially 
across the thickness of the retina. The neural layer attaches to the RPE layer, which is the 
outermost layer of retina (Ross & Pawlina 2005).   
 
 
2.3.2 Retinal pigment epithelium 
 
Retinal pigment epithelium is an epithelial cell monolayer located in retina between neural 
retina and choriocapillaris (Strauss 2005). Like other epithelial cells, RPE is an avascular 
tissue where cells adhere to one another by means of specific cell-to-cell adhesion molecules 
that form specialized cell junctions. Epithelial cells are polarized so that they are associated 
with three distinct morphologic surface domains; apical, lateral and basal domain. Apical 
domain can be considered as the surface of the cells that is exposed to the environment, as 
later domain consists of the sides of the cells (cell-cell contacts) and basal domain is the 
surface epithelial by which the cell is attached to the extracellular matrix. The properties of 
each domain are determined by specific lipids and membrane proteins. The basal surface 
usually is attached to an underlying basement membrane, which for RPE is the Bruch’s 
membrane. RPE is formed of hexagonal cells that are densely packed with melanin 
containing light-absorbing pigment granules called melanosomes that prevent reflection of 
the light and resultant glare (Ross & Pawlina 2011.) 
 
RPE functions as a selective barrier that facilitates or inhibits the passage of specific 
substances between the exterior environment and the underlying tissue compartment. It 
secretes growth factors, regulates nutrient, ion and molecule transport between subretinal 
space and bloodstream by forming the blood-retina barrier (BRB) (Curcio & Johnson 2013, 
Ross & Pawlina 2011.) RPE has also many other crucial functions in the retina; it also 
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phagocytoses the shed membranous discs from photoreceptor outer segments (POS), regen-
regenerates visual pigment and takes part in the visual cycle by the vitamin A metabolism.  
In vitamin A metabolism, regeneration of retinoids requires molecule exchange between the 
photoreceptors and the RPE. These functions have been illustrated in figure 2.  
Dysfunctional RPE can cause impairment and death of the photoreceptor cells, and may 
eventually to deterioration or total loss of vision.  (Strauss 2005, Vaajasaari et al. 2011)   
 
Adjacent RPE cells are connected by a junctional complex that forms the inner blood-retina 
barrier. On the basal side of the RPE layer lays the outer limit of retina, basal membrane 
known as Bruch’s membrane (Strauss 2005, Ross & Pawlina 2011.) Bruch’s membrane 
plays a crucial role together with RPE cells in maintaining photoreceptor viability as well as 
overall retinal health. Bruch’s membrane anchors the RPE cells from their basal membrane 
via tight junctions and connects the RPE into the choroid. RPE forms in the other, outer 
BRB in collaboration with Bruch’s membrane and the choriocapillaris (Rizzolo et al. 2014.) 
Basement membrane–forming collagens in the Bruch’s membrane include type IV collagen, 
which is responsible for the collagen suprastructure in the basement membrane of epithelial 
cells (Ross & Pawlina 2011). The RPE’s basal surface participates in metabolic exchanges 
with the blood vessels in the underlying choriocapillaris (Bonilha 2008). 
 
 
FIGURE 2. Major functions of the RPE (Modified from Lehmann et al. 2014)  
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2.3.3 Retinal degeneration 
 
A collection of structural changes occur in aging eyes. Over time, overall thinning is 
apparent in the aged retina due to loss of neurons from all the neuronal cells and changes in 
photoreceptor cells.  The RPE specifically is known to undergo several structural alterations. 
These alterations include changes in density and coactions with Bruch’s membrane, loss of 
melanin granules, and even cell apoptosis (Bonilha 2008.) Dysfunction or deterioration of 
RPE is linked to degenerative retinal diseases, such as age-related macular degeneration 
(AMD) and retinitis pigmentosa (RP) (Strauss 2005). 
 
Age-related macular degeneration is a disease characterized by a breakdown of the macula. 
Macula is a relatively small area in the central retina that is responsible for the majority of 
useful photopic vision and almost 10 % of the entire visual field (Hageman 2014.) AMD 
occurs in two forms: neovascular or exudative (wet) and atrophic (dry) AMD. The rarer but 
more intense form of AMD, wet AMD, is characterized by abnormal growth of blood vessel 
from the choroid into the Bruch’s membrane and RPE. Wet AMD covers approximately 
20% of the AMD conditions. It results ultimately in severe, sudden visual loss by forming a 
scar in the macula. Dry AMD causes gradual loss of central vision due to the dysfunction or 
death of RPE and subsequent death of photoreceptor cells (Bonilha 2008.) AMD develops 
usually in later decades of life, but has been diagnosed in patients even in their forties. AMD 
causes loss of bilateral vision and is the leading cause of worldwide blindness in elder 
people (Chakravarthy et al. 2010.)  
 
RPE degeneration is the most leading causes of blindness. Retinitis pigmentosa (RP) is the 
most common group of inherited eye disorders that are caused by damage in the retina. 
There are many variations of the disease, but common to all of them is retinal dystrophy 
caused by abnormalities of the photoreceptors or the RPE. This degeneration of retina is 
progressive and has no known cure (Jin et al. 2009.) Other typical retinal dystrophies 
include Stargardt’s macular dystrophy, Best vitelliform macular dystrophy (BVMD,) also 
known as Best’s disease, and diabetic retinopathy (Finnish Federation of the Visually 
Impaired, 2014.) High eye pressure as symptom of untreated glaucoma can cause blindness 
by damaging retinas sensor cells. Unlike many other retinal degeneration diseases, glaucoma 
can be effectively treated with medicine or surgery (Haug et al. 1999). 
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Since many diseases that cause retinal dystrophy are not currently treatable in other ways, 
cell replacement therapies are considered as a solution to these conditions. Treatment could 
be performed replacing damaged cells with healthy ones (Lund et al. 2006.) In RPE related 
diseases, clinical trials that utilize ESC-RPE cells in treatment of AMD are currently 
ongoing (Bharti et al. 2014) and so far the results have been promising (Schwartz et al. 
2014). The cell replacement can be done by either direct injection of RPE cell suspension 
(Schwartz et al. 2012) or as transplant of RPE cell sheet (Cyranoski 2014a) into the 
subretinal space. Cell sheet grafts may be a better option, since with cell suspension 
injections involve many uncontrollable variables. When injected as suspension, the cells 
might fail to form a functional monolayer by not adhering to Bruch’s membrane or by 
acquire an incorrect apical-basal orientation (da Cruz et al. 2007.) 
 
In Japan, permission has been recently granted to use hiPSC-RPE in clinical trials 
(Cyranoski 2014a). The first treatment, executed after four days of the permission, was done 
by Masayo Takahashi, an ophthalmologist with years of study in the field of iPS-cells. Trial 
was performed with the use of hiPSC-derived RPE cells as a treatment of AMD (Cyranoski 
2014b.)  
 
 
2.4 Differentiation of human pluripotent stem cells into RPE cells 
 
While hPSCs can differentiate to RPE cells, current differentiation protocols are inefficient 
and not optimal for clinical translation. The currently used protocols for RPE cell 
differentiation from hPSCs are mostly based on spontaneous differentiation that results in 
low yields (Klimayanska et al. 2004.) Phenomenon happens especially while deriving RPE 
cells from hiPSC lines (Rowland et al. 2013.) Effective culture methods and differentiation 
protocols are therefore needed and thus induction of differentiation can be used to guide 
differentiation towards defined cell type.  
 
The differentiation of hPSC-RPE can be carried out in either adherent or EB-like culturing 
conditions. EB-like culturing is a widely used differentiating method (Idelson et al. 2009; 
Klimanskaya 2004; Klimanskaya 2006; Vaajasaari et al. 2011).  As differentiation towards 
RPE cells progresses, pigmented areas start to develop on the EBs. These areas can then be 
selected and used to create monolayer cultures for further RPE enrichment and maturation 
20 
 
 
 
(Klimanskaya 2006.) Adherent differentiation can be used for generation of hPSC-RPE as 
well. Differentiation in adherent cell culture is usually carried out by removing the fibroblast 
growth factor (FGF) from the culturing medium, and stem cell colonies are let to overgrow 
and form a homogenous cell layer. Adherent cell culture could be suitable for hPSC-RPE 
differentiation, since RPE cell are epithelial cell that tend to grow in native conditions in 
monolayer (Vugler et al. 2008.) Adherent differentiation is used in hPSC-RPE culturing 
beside the EB-culturing (Carr et al. 2009, Klimanskaya 2006, Liao et al. 2010, Rowland et 
al. 2013, Vugler et al. 2008). 
 
When subcultured, epithelial cells lose their cell-cell adhesion. These dissociated cells gain 
migratory and invasive properties through epithelial-mesenchymal transition (EMT) and 
temporary form a fibroblast-like morphology before they revert to their original RPE-like 
morphology. (Lee et al. 2010; Vugler et al. 2008).  EMT is a process by which epithelial 
cells lose their differentiated phenotypes and transdifferentiate into motile mesenchymal-like 
cells (Tamiya et al. 2010).  Propagated RPE cells also lose their pigmentation as 
melanocysomes are exocytoced or diluted by cell division. After RPE cells gain their 
polygonal uniformity, confluent cobblestone morphology, they start to gain back their 
melanin pigmentation (Klimanskaya 2006). 
 
 
 
2.4.1 Spontaneous differentiation 
 
Currently, the widely used derivation methods in development of RPE-cells from hPSCs 
favor spontaneous differentiation (Carr et al. 2013, Klimanskaya 2004 & 2006, Liao et al. 
2010, Vaajasaari 2011, Vugler et al. 2008). When there are no known inductive agents in the 
culturing medium, ESCs tend to differentiate towards a neural pathway (Smukler et al. 
2006). RPE being derivative of the neuroectoderm can be thus produced with this default 
differentiation pathway (Fuhrmann 2010).  
 
When differentiating hPSC toward RPE cells, over time the RPE-like cells can be easily 
observed as they form distinguishable grey or black melanin pigmentation (Ross 2005). 
These areas on EB-like cell aggregates or adherent cultures can be then dissociated and 
placed in adherent culture to develop more homogeneous and mature cell cultures 
(Vaajasaari et al. 2011). 
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2.4.2 Induction toward RPE-cell differentiation 
 
As the spontaneous differentiation protocols of hPSC-RPE result in low yields, new methods 
are needed to produce cells more efficiently for clinical applications (Klimayanska et al. 
2006). The spontaneous differentiation tends to favor neuroectodermal differentiation, but it 
has also been shown that ESC-derived ectoderm can give rise to cells of both neural and 
epidermal lineage. Spontaneous differentiation results in heterogeneous cell populations, and 
since melanocytes are derivatives of the epidermis, they may be mistaken for RPE cells due 
to the fact that they also produce melanin and are therefore pigmented (Watabe & Miyazono 
2009.) Effective culture methods and differentiation protocols are therefore needed and thus 
induction of differentiation can be used to guide differentiation towards defined cell type.  
 
It has been suggested that the extracellular matrix can affect the cell differentiation, and 
therefore changes in ECM composition may improve the derivation of RPE-cells from 
pluripotent stem cells (PSC). In study published by Rowland et al. in 2013, several purified 
ECM proteins were tested for their ability to support iPSC-RPE differentiation and 
maintenance. The results showed that iPSCs differentiated on nearly all tested substrates 
developed melanin pigmented regions. However, although iPSC-RPEs cultured on the 
majority of the tested substrates expressed key RPE genes, only six substrates supported 
development of confluent monolayers with normal RPE morphology (Rowland et al. 2013.)  
 
The differentiation can be directed also in other ways, where one method is a use of a 
specific culturing medium composition (Carret et al. 2013; Idelson et al. 2009). One method 
developed within the ophthalmology group was originally used in deriving corneal 
epithelial-like cells from hiPSCs (Mikhailova et al. 2014), but preliminary tests have also 
been conducted within the group in deriving hPSC-RPEs (data not published). Method 
replicates early developmental mechanisms in the eye by blocking the transforming growth 
factor β (TGF-β) and Wnt-signaling pathways with small molecule inhibitors while 
activating fibroblast growth factor signaling. This induction method is based on a use of 
basic fibroblast growth factor and two small molecules, SB-505124 and IWP-2. (Mikhailova 
et al. 2014.) 
 
Basic fibroblast growth factor belongs to a family of polypeptide fibroblast growth factors 
that are involved in multiple functions. In normal tissue, basic fibroblast growth factor is 
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present in basement membranes and in the subendothelial extracellular matrix of blood ves-
vessels (Ross & Pawlina, 2011.)  Studies have shown that the bFGF may have a role for 
example in cell proliferation, survival, differentiation and motility (Watabe & Miyazono 
2009). bFGF may also play a part in inducing of RPE proliferation and in the 
transdifferentiation of RPE cells into neural progenitor cells (Klimanskaya 2006). In the 
culture medium bFGF will cause EMT process while speeding up cell proliferation, 
providing in the end a formation of a confluent RPE monolayer (Tamiya et al. 2010). 
 
Small molecule SB-505124 (2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-
methylpyridine hydrochloride) is a selective inhibitor of various transforming growth factor-
β type I receptors. SB-505124 also blocks more complex endpoints of TGF-β action, as 
evidenced by its ability to abrogate cell death caused by TGF-β1 treatment (Byfield et al. 
2003.) The TGF- β superfamily includes transforming growth factor (TGF), activins, and 
bone morphogenetic proteins (BMPs). They regulate a wide range of responses in the cell, 
including cell proliferation, differentiation, adhesion, migration, and apoptosis (Sporn & 
Roberts 1990, Byfield et al. 2003.) 
 
IWP-2 (N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-
d]pyrimidin-2-yl)thio]-acetamide) is small molecule that acts as inactivator of Porcn 
function. IWP-2 also inhibits a signal transduction pathway called Wnt production, and 
blocks β-catenin accumulation. Wnt/β-catenin pathway affects the ability of stem cells to 
remain pluripotent and affects also the undifferentiated retinal progenitor by inducing the 
formation of the laminar structure of the retina (Mikhailova et al. 2014, Vugler et al. 2008.) 
 
 
2.5 RPE-cell characterization 
 
There are numerous different types of differentiated cells in human, and thus specific 
markers for certain cell type are needed to distinguish one cell from another. RPE-like cells 
can be distinguished by their specific morphology, expressed gene and protein markers and 
functionality. 
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2.5.1 Morphology 
 
Most mammalian cells can be divided into three basic categories based on their morphology. 
These categories are fibroblast-, epithelial- and lymphoblast-like cells. Epithelial cells, like 
RPE, grow attached to a substrate in discrete patches and their shape is mostly polygonal 
with more regular dimensions (Life Technologies 2014.) 
 
RPE-cells are bipolar cells which form a hexagonal cell monolayer.  RPE is densely packed 
with pigment granules called melanocytes, which results in distinct brown or black color 
from melanin pigment. Hexagonal morphology of RPE resembles cobblestone or 
honeycomb type of formation (Maminishkis et al. 2006.) The RPE cells form tight, adherent 
and gap junctions between cells which create a blood-retinal-barrier between the retina and 
choriocapillaris (Strauss 2005). 
 
 
2.5.2 Transepithelial resistance 
 
Transepithelial resistance (TER) measures the epithelial layer’s ability to resist current or 
diffusion of the ions across it. The measuring can be performed with either Ussing chamber 
or a voltohmmeter. TER depicts the development of epithelial barrier properties and tight 
junction formation between the cells (Carr et al. 2013.) Thus, TER can be used to analyze 
the formation of the RPE epithelial cell monolayer. Transepithelial resistance values 
measured from RPE-cells vary in different studies as shown in table 1. TER-values seem to 
be affected by the source of the cells, days of the culturing, measurement conditions and 
overall information of how the cells have attached to the surface and have been able to form 
resistant tight junctions. The selection of measurement system has also a great impact on the 
results. 
 
Tight junctions, also known as zonula occludens, are found in the most apical component in 
the junctional complex between epithelial cells. Their function is to hold the cells tightly in 
close connection and also form a barrier that seals of the intracellular space. Zonula 
occludens strands correspond to the location of the rows of transmembrane proteins. Three 
major transmembrane groups found in zonula occludens are occludin, claudins are 
junctional adhesion molecules (JAM) (Ross & Pawlina 2011.) 
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TABLE 1. Transepithelial resistance of RPE cells in literature. 
Reference Tissue TER (Ω· cm2) 
Frambach et al. 1990 Cultured human RPE 330 
Quinn & Miller 1992 Human adult RPE 79±48 
Quinn & Miller 1992 Human fetal RPE 206±151 
Maminishkis et al. 2006 Human fetal RPE 501±138 
Vaajasaari et al. 2011 putative hESC-RPE d30 6-32 
Vaajasaari et al. 2011 putative hESC-RPE d60 145-188 
Vaajasaari et al. 2011 putative hESC-RPE d90 311 
Vaajasaari et al. 2011 putative hiPSC-RPE d30 6-10 
Vaajasaari et al. 2011 putative hiPSC-RPE d60 23-38 
Vaajasaari et al. 2011 putative hiPSC-RPE d90 74 
Peng et al. 2014 Human fetal RPE 500 - 2000 
 
 
2.5.3 RPE specific proteins 
 
Immunofluorescence (IF) staining is a method that applies immunochemistry in a way to 
image specific substances.  IF utilizes fluorophores and antibodies that are labeled with 
fluorescent dye (Wilson & Walker 2010.) Antibodies, or immunoglobulins, are proteins 
produced by plasma cells. They bind specifically to particular substances, referred as 
antigens (Ross & Pawlina 2011.) Antibodies can be used to visualize the distribution of a 
specific biomolecule with an antibody that recognizes the examined protein as antigen and 
binds to it. Fluorescent antibody complex can be formed by direct or indirect method 
(Wilson & Walker 2010.) 
 
Direct method applies the antibody labeled with fluorescent dye directly to the antigen. 
Indirect method utilizes two different antibodies, where one recognizes the target protein 
and another contains the fluorescent label. In indirect method first the primary antibody that 
recognizes the antigen binds to the target biomolecule. Secondly, the secondary antibody 
with the fluorescent label binds to the primary antibody, forming this way a fluorescent 
complex.  The fluorescence can be detected by fluorescent microscope after illuminating the 
sample with dye-specific excitatory wavelength (Wilson & Walker 2010.) 
 
There are several known molecular markers of the RPE. Most distinct markers that RPE-like 
cells express are for example cellular retinaldehyde-binding protein (CRALBP), retinal 
pigment epithelium-specific 65 kDa protein (RPE65), bestrophin and pigment epithelium 
derived factor (PEDF) (Klimanskaya 2004.)  Cultured RPE cells differ in gene expression 
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on different time points and hence functionality depends on cell passage and degree of epi-
epithelial polarization (Mazzoni et al. 2014.) For example, in mature hESC-RPE cells, the 
expression of genes that are involved in visual cycle should be-up-regulated (Liao et al. 
2010). 
 
Cellular retinaldehyde-binding protein (CRALBP) is a protein that takes part in the visual 
cycle by functioning as a substrate carrier protein that modulates interaction of retinoids (11-
cis-retinaldehyde). CRALBP is expressed in RPE cells, but is present also in Müller cells in 
the retina (Saari & Crabb 2005.) Retinal pigment epithelium-specific 65 kDa protein 
(RPE65) is involved in the visual cycle by taking part in the conversion of all-trans retinol to 
11-cis retinal during photo-transduction. RPE65 also regenerates the visual pigment in 
photoreceptor cells. (Cai et al. 2009)  
 
Bestrophin, a product of the Best vitelliform macular dystrophy gene, is commonly used 
molecule marker in RPE cells (Klimanskaya et al. 2004, Burke et al. 2008). As one of the 
roles of RPE is to transport nutrients and ions between the choriocapillaris and 
photoreceptors, the bestrophin, as a type of calcium-activated anion channel, plays important 
role specifically in cloride conductance and calsium signalling in the RPE cells (Hartzell et 
al. 2008.) 
 
 
2.5.4 Proteins indicating the polarity of the cells 
 
RPE cells are polarized epithelial cells. Transmembrane proteins expressed in RPE cells 
include proteins such as sodium-potassium-adenosine triphosphatase (Na+/K+ -ATPase) and 
tight junction proteins zonula occludens 1 (ZO-1) and claudin-19 (Lehmann et al. 2014, 
Rizzolo 2014).  
 
Sodium-potassium- adenosine triphosphatase (Na+/K+ -ATPase) is an ion pumping protein 
complex located in cell membrane. This pump is essential for the maintenance of Na+ and 
K+ ion concentrations across the membrane. Energy for transepithelial transport is provided 
by Na+/K+ -ATPase on the apical membrane of RPE cells (Lehmann et al. 2014.)  
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ZO-1 is one of the zonula occludens proteins. ZO-1 is an important link in transduction of 
signals from all transmembrane proteins (Ross & Pawlina 2011.)  It is a transmembrane 
protein that is located on the apical (cytoplasmic) side of RPE-cell (Rizzolo 2014).  
 
Claudins are transmembrane proteins that form the backbone of zonula occludens strands. 
They form and regulate aqueous channels used in paracellular diffusion (Ross & Pawlina 
2011.) Claudin-19 is a protein that is an essential component of human RPE tight junctions 
since patients with genetic defect of claudin 19 suffer profound ocular deficits (Konrad et al. 
2006.)  It has been shown that claudin-19 is the dominant claudin expressed in cultured 
RPE-cells and it is the only claudin that was identified as RPE-specific when compared with 
photoreceptors and choroid (Peng et al. 2011). 
 
 
2.5.5 Other characterization methods 
 
Along with other vital functions in the retina, phagocytic activity is a core trait of RPE cells 
in vivo and in culture. Continuous renewal of the light-sensitive outer segment portions of 
photoreceptors is critical for vision and thus the phagocytosis by RPE cells is highly 
regulated and specific for spent outer segment fragments.  Phagocytic processes consists of 
three distinct phases; recognition/binding, internalization, and digestion. (Mazzoni et al. 
2014.) RPE cells are the most actively phagocytic cells in the human body. One RPE cell 
supports 30–50 photoreceptors, which shed daily ~5% of their outer segment mass (Bonilha 
2008). In situ analysis of RPE phagosomes has identified essential proteins of the RPE 
phagocytic machinery. These phagosomes in the RPE may be identified by different 
microscopy techniques based on their sizes and location in the RPE (Mazzoni et al. 2014.) 
 
Immunolabeling any outer segment protein may aid in identification of RPE phagosomes, 
but rhodopsin is the most ideal to immunolabel, since it is the most abundant protein in rod 
outer segments. The RPE cells do not express rhodopsin themselves and rhodopsin content 
of the RPE therefore will correlate directly with relative phagocytic load. (Mazzoni et al. 
2014.) POS phagocytosis can be also tested with specific assays and quantification method 
that utilize for example latex beads (Klimanskaya 2006). 
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3 AIMS OF THE STUDY 
 
The objective of this Bachelor’s thesis was to further optimize a directed RPE differentiation 
method developed in the Skottman Ophthalmology group by providing knowledge on the 
differences between the efficiency of the adherent and EB-like culturing methods in the dif-
ferentiation of RPE-like cells from human pluripotent stem cells. When more efficient ways 
to produce RPE-cells are discovered, these methods could be utilized in tissue engineering 
applications. In the future, disorders caused by retinal degeneration could be cured by apply-
ing regenerative medicine, where the damaged RPE would be replaced by tissue graft de-
rived from hPSCs.  
.. 
The aim of the study was to compare adherent and EB-like differentiation methods in di-
rected differentiation of hPSCs into RPE. The main points of interest were to evaluate the 
formation of melanin pigment producing cells between the differentiation methods and to 
analyze of the quality of the produced cells. The cell lines chosen for this study were a 
hESC-line that is commonly used in differentiation of hESC-RPE within the research group, 
and one human iPSC-line for comparison. 
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4 MATERIALS AND METHODS 
 
The experiment consisted of two separate phases. The initial differentiation phase consisted 
of chemical differentiation induction in EB cultures followed by comparison of the EB ver-
sus adherent culturing methods by the rate of melanin pigmented cells produced. In the fol-
lowing phase, the produced pigmented cells were selected for subculturing and characterized 
by TER and immunofluorescence stainings to determine their barrier junction properties, 
differentiation state, polarity and expression of RPE typical proteins. Course of the experi-
ments are described in table 2. Experiments were performed following good laboratory prac-
tice (GLP) whenever possible.  
 
TABLE 2. The course of the study  
Method Number 
of days 
Introduction of the method 
Induction of differentiation d0 Stem cells colonies were mechanically cut and the pieces 
were placed in low attachment 6-well plate for differen-
tiation in induction medium. The colonies form a three-
dimensional aggregate, called EB (figure 3.) 
 d4 EBs are divided into two groups of equal size. One group 
continues to differentiate as EBs in suspension culture, 
the other group is transferred to collagen IV coated ad-
herent culturing 6-well plate. The induction medium is 
replaced with basic cell culturing medium. 
Subculture  ~d40 The differentiated, RPE-like pigmented areas of cultures 
are mechanically selected and dissociated to single cell 
suspension. The cells are counted with hemocytometer 
and seeded to collagen IV coated 24-well plates and per-
meable (Polyethylene Terephthalate) PET-membrane 
inserts.  
TER measurements d40 + 5-7 
weeks 
TER is measured from PET-membrane cultures.  
Immunostainings d 40 + 5-7 
weeks 
The PET-membrane cultures are stained with RPE-
spesific antibodies and imaged with confocal microscopy. 
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4.1 Cell culture 
 
 
4.1.1 Human pluripotent stem cells 
 
Cell lines used in this study were hESC line Regea 08/017 previously derived in research 
group’s laboratory (Skottman 2010) and hiPSC line UTA.04511.WTs. Two different batches 
of both cell lines were used to evaluate the pigmentation rate. The pluripotent cell lines were 
handled in sterile conditions and cultured in humidified incubators (Thermo Electron Corp., 
Waltham, MA, USA) at +37 °C in 5% CO2 on mitotically inactivated (by mitomycin C) 
hFF (36,500 cells/cm2; CRL-2429; American Type Culture Collection, ATCC, Manassas, 
VA) in serum-free conditions (Vaajasaari 2010) and passaged with single cell enzymatic 
dissociation (SCED) –method. 
 
Research group gets the embryos for derivation of hESC lines as a donation from couples 
that have gone through fertility treatments and signed an informed consent form. The sur-
plus embryos are unfit to be used in the treatments and would have otherwise been disposed 
of. Group leader Heli Skottman has the approval of the National Authority for Mediolegal 
Affairs Finland to study human embryos (Dnro1426/32/300/05) and has the support of the 
Ethical Committee of the Pirkanmaa Hospital District (R05116) to derive, culture and dif-
ferentiate hESC lines from surplus embryos (Skottman 2010.)  
 
Human iPSC line used in this study is a wildtype line inducted with Sendai-virus method. 
Line is mainly used in BioMediTech research group led by Katriina Aalto-Setälä. Aalto-
Setälä’s group does research in the field of cell - and tissue technology, focusing on heart 
cells. The hiPSC-line is used as a control cell line in the studies and it is formed within Uni-
versity of Tampere from patient skin biopsy (Haponen 2014.) 
 
Basic hPSC culture medium consisted of Knockout Dulbecco’s Modified Eagle Medium 
(KO-DMEM) containing 20% KnockOut Serum Replacement (KO-SR), 2 mM glutamine 
mixture (GlutaMax), 0.1 mM β-mercaptoethanol, 1% Minimum Essential Medium nones-
sential amino acids, (all from Invitrogen, Carlsbad, CA) 50 U/ml penicillin/streptomycin 
(Cambrex Bio Science, Walkersville, MD), and 8 ng/ml human basic fibroblast growth fac-
tor (bFGF; R&D Systems Inc., Minneapolis, MN) (Vaajasaari 2010). 
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4.1.2 Differentiation and culture media 
 
The basic differentiation culture medium (called DM-) is used normally in spontaneous dif-
ferentiation within the research group (Vaajasaari et al. 2010). DM- consists of basic growth 
medium KO-DMEM that is supplemented with 15% KO-SR, 50 U/ml penicil-
lin/streptomycin, 1% non-essential aminoacids, 1% GlutaMax and β-mercaptoethanol. 
 
The differentiation of the cells was induced by adding basic fibroblast growth factor (human 
FGF-basic 50 µg, PeproTech) and small molecule selective inhibitors SB505124 and IWP-2 
(both from Sigma-Aldrich, Sigma Life Sciences) to DM- medium, that was thus being called 
as DM+ medium. The induction method is based on knowledge provided previously in the 
research group (Mikhailova et al. 2014; unpublished data.) DM+ medium used in induction 
was changed 2-4 times during the first four days of differentiation. After the induction, cells 
were transferred to the DM- medium. DM- medium was changed three times a week. 
 
 
4.1.3 RPE differentiation 
 
The human pluripotent stem cells were grown with supportive feeder cell layer of human 
foreskin fibroblasts. For differentiation, the stem cell colonies were mechanically cut and 
undifferentiated areas selected from the culturing wells and passaged to 6-well plate (Costar 
multiwell plate, 6-well Ultra-Low attachment surface, Corning Incorporated) with differen-
tiation medium DM+. The passaged colonies formed floating cell aggregates spontaneously 
as they were placed on the medium. The method is demonstrated in figure 3. 
 
Directed differentiation by small molecule induction took place for four first days of the 
differentiation. On d4 the medium was changed to basic culturing medium DM- and the 
formed EB-like cell aggregates were either kept in the EB suspension culture or transformed 
to adherent culture conditions. Adherent culturing took place on 6-well plate (Costar multi-
well plate, 6-well Corning CellBind Surface, Corning Incorporated.) The wells were coated 
with Collagen IV (Sigma-Aldrich) 5 µg/cm2. EB-like cell aggregates attached to the coated 
bottom of the well and started to form an adherent culture.  
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FIGURE 3. Overview of mechanical selection of stem cell colonies. (A) Stem cell colonies viewed 
by phase contrast microscope, picture taken through oculars. 1x magnification (B) Undifferentiated 
stem cell colonies on top of feeder cells. (C) & (D) Cutting was done by scalpel and colonies were 
unfastened from bottom of the well. (E) Colonies floating free in the medium (d0) (F) Colonies form 
EB-like cell aggregates within a day from the selection (d1) Pictures B-F magnification 4x, scale bar 
200 µm. 
 
The differentiation potentials of the adherent and EB-like culturing methods with hESC and 
hiPSC lines were analyzed by the appearance of the first pigmented cells emerging from 
each cell line. Observations were done five times a week with phase contrast light micro-
scope (Nicon eclipse TE2000-5.) Pictures were taken in different time points to document 
the development of melanin pigmentation with camera attached to the microscope (Nikon 
Digital Sight DS-L5) 
 
After 42 days of differentiation, pigmented areas were cut mechanically and passaged with 
SCED to Collagen IV coated 24-well plates and PET-membranes on culturing well inserts. 
The meaning of subculture was to gain more homogenous epithelial like RPE-cultures. 
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4.1.4 Subculture  
 
For enrichment and maturation of the RPE-like cell produced, the areas with pigmented cells 
were chosen manually with a scalpel in sterile conditions and subsequently dissociated and 
passaged to a different well plate. Passaging was performed within d41-d42 of the initiation 
of differentiation. Usually longer differentiation develops better yield of pigmented cells, but 
in the limited timescale for the project, this step had to be performed with modest amounts 
of pigmented cell material. 
 
After mechanical separation, cells were washed two times with Dulbecco’s phosphate-
buffered saline (DPBS.) A proteolytic enzyme with brand name TrypleSelect was used to 
dissociate the cells for 10-15 min at +37 C°. The cells were carefully triturated and put in 
DM- medium through 4.0 µm nylon cell strainer to gain a single cell suspension. Cell sus-
pension was then centrifuged at 1500 rpm for 5 min. Medium containing TrypleSelect was 
removed and cells were resuspended to 1 ml of DM- and counted with hemocytometer. Rea-
gents were manufactured by Invitrogen, Life Technologies. 
 
The cells were plated either on collagen IV (5 µg/cm2; Sigma-Aldrich)-coated 24 well plates 
(42 000 – 56 000 cells/cm2; Costar multiwell plate, 24-well Corning CellBind Surface, 
Corning Incorporated) for pigmentation and morphology follow-up, or on permeable Colla-
gen IV–coated PET-membrane inserts (100 000 – 200 000 cells/cm2; Millicel 24-well hang-
ing cell culture insert, 1,0 µm PET transparent, Millipore) for immunofluorescent stainings. 
 
 
4.2 Reference material 
 
To analyze the cells produced in this study, two hESC-RPE cell cultures were taken to the 
characterizations as reference material. The reference cells were produced within the group 
from the same hESC-line as the cells used in the study. Adherently differentiated hESC-RPE 
cells were compared to control cell cultures. Purpose of the reference material was to use 
them as control samples to see if there was a difference in the quality of the cells produced 
with induction and spontaneous differentiation methods. The controls were named based on 
their differentiation mediums DM- and DM+/DM- as M- and M+/M-, respectively.  
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The control cell M- cultures was produced with spontaneous differentiation process (method 
used previously in Mikhailova, 2011 and Vaajasaari et al., 2011) and the another control 
M+/M- represented a type of parallel sample by being derived with same directed differenti-
ation method as the adherently differentiated hESC-RPE sample.  
 
The comparison of the control cells and the adherently differentiated hESC-RPE cell sample 
is presented on table 3. The passage number is counted from each subculture of the original-
ly differentiated RPE-like cells. Control M- cells were spontaneously differentiated in EB-
form in DM- medium (passage +1), without small molecule or growth factor induction. Af-
ter 58 days of differentiation, pigmented areas were cut mechanically (passage +2), and plat-
ed to collagen IV coated 24-well plates without SCED treatment as cell clusters. After RPE-
like cells had gained confluence for 68 days on passage +2, they were passaged to collagen 
IV coated PET-membrane on culturing well inserts (passage +3).  
 
The control cells called M+/M- were differentiated with same method as study inserts, first 
four days on DM+ and then DM- medium. Only difference is on that these cells were plated 
to inserts on their passage +3 after they had formed confluent RPE-like colonies on 24-well 
plate in passage +2. Differentiation in first passage took 47 days, and maturation on second 
passage 36 days.  
 
TABLE 3. Comparison of the sample cells and the control cells 
Type  (name) Diff. method Medium Diff. culturing 
condition 
Passage 
on insert 
Control M- spontaneous DM- EB +3 
Control M+/M- directed DM+/DM- adherent +3 
Sample hESC adherent directed DM+/DM- adherent +2 
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4.3 Transepithelial resistance 
 
Transepithelial resistance was measured from the sample and control culture inserts. Meas-
urement devise used in the study was Millicell Electrical resistance system 2 voltohmmeter. 
The measurement electrodes were disinfected by keeping them ~15 minutes (min) in 70% 
ethanol. Electrodes were let to dry in the room temperature (RT) before they were used in 
the measurements. For stabilization, the electrodes were rinsed in two different falcon tubes 
that contained PBS before every measurement. The PET-membranes were in the DM- medi-
um during the measurements. Measuring was performed 2-3 times to each sample and a 
blank control. The resistance measurements were averaged and the value of the blank was 
subtracted from the sample-well resistance. 
 
 
4.4 Immunofluorescence staining 
 
Immunofluoresce stainings were performed to detect expression of commonly used RPE-
spesific marker proteins by the cells. Imaging with confocal microscope enabled the anal-
yses of the polarization of the marker proteins.  
 
The cells were washed three times with PBS and fixed with 4% paraformaldehyde (pH 7.4; 
Sigma-Aldrich) for 10 min at RT following repeated washings with PBS. The cells were 
made permeable by incubating in 0.1% Triton X-100 in PBS (Sigma-Aldrich) at RT for 10 
min. The unspecific binding sites were then blocked by treating cells with 3% BSA (BSA; 
Sigma–Aldrich) at RT for 1 hour (h) and the PET-membranes were cut to three or four piec-
es. Samples were incubated overnight at +4 °C with primary antibodies shown in table 4. 
Dilutions were prepared in 0.5% BSA in DPBS. Cells were washed three times with PBS 
and labeled with secondary antibodies shown in table 5. Secondary antibodies were diluted 
in 0.5% BSA-PBS and incubated 1.5 h at RT following repeated PBS washings. The nuclei 
were stained with 4 ́, 6 ́ diamidino-2-phenylidole (DAPI) included in the mounting media 
(Vector Laboratories Inc.)  
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TABLE 4. Primary antibodies 
Primary antibodies Manufacturer / Product code Dilution 
mouse anti-Na+/K+ -ATPase Abcam / ab7671 1:200 
rabbit anti-bestrophin Abcam / ab14928 1:200 
mouse anti-RPE-65 Millipore / MAB5428 1:200 
rabbit anti-ZO-1 Life technologies / Novex 61-7300 1:200 
mouse anti-CRALBP Abcam / ab15051 1:500 
mouse anti-claudin-19 Millipore / MAB6970 1:100 
 
TABLE 5. Secondary antibodies 
Secondary antibodies Manufacturer / Product code Dilution 
donkey anti-mouse IgG A488 Life Technologies / Alexa Fluor A-21202 1:800 
goat anti-rabbit IgG A568 Life Technologies / Alexa Fluor A-11011 1:800 
 
 
The control cell cultures M- and M+/M- on PET-membranes were stained using all of the 
primary antibodies listed in table 4. Due to the poor outcome, the hESC-RPE cell cultures 
produced in this study were stained using only anti-Na+/K+ ATPase, anti-BEST, anti-
CRALBP and antiZO-1 leaving out the RPE65, and the other tight junction protein, anti-
claudin-19, which show usually only in well matured RPE-like cells.  
 
At time of the immostainings, the cell cultures control DM-, control DM-/DM+ and hESC-
RPE sample had been on the culturing inserts for 106 days, 91 days and 40 to 49 days, re-
spectively.  Images were taken with an LSM 700 confocal microscope (Carl Zeiss, Jena, 
Germany) using a 63×oil immersion objective.  
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5 RESULTS 
 
The actual time points for each step of the experiment are shown up in the figure 4 and are 
discussed in detail in the following chapters. 
 
 
FIGURE 4. Course of the practical work. *Some of the cells were passaged only on 24-well plates, 
but they did not manage to form a subculture. 
 
 
5.1 Appearance of pigmentated cells 
 
Appearance of pigmented cells was followed daily, excluding weekends. The formation of 
the pigmentation is presented in figure 5. The observations for each cell lines and culturing 
conditions are shown on table 6. The comparison of cell differentiation in different culture 
conditions can be seen in the images in figures 6 and 7. Figures 6 and 7 represents the dif-
ferentiation of hESC line and hiPSC line on the 39th day of differentiation, respectively. The 
differentiation potentials of the culturing methods can be compared by the amount pigment-
ed cells emerging from each cell line. 
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FIGURE 5. Melanin pigmentation development (A) Suspension culture, no pigmentation on EBs on 
(hESC, d11) (B) First sign of pigmentation on EB (hESC, d21) (C) Developed pigmentation on EB, 
(hESC, d35) (D) Adherent culture, no pigmentation (hESC, d6) (E) First signs of pigmentation on 
adherent culture (hESC, d21) (F) Well pigmented adherent culture (hESC, d35.) Magnification 4x, 
scale bar 200 µm. 
 
 
TABLE 6. Summary of the pigmentation formation  
Cell line / conditions Pigmentation first shown 
hESC adherent d17-d21 
hESC EB d18-d22 
hiPSC adherent d17-d19 
hiPSC EB d26-d28 
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FIGURE 6 hESC line, day 39 of differentiation (A) adherent culturing conditions, overview. (B) 
adherent culturing conditions, close-up. (C) EB-like culturing conditions, overview. (D) EB-like 
culturing conditions, close-up. Some of the pigmented areas are marked with arrows. 
 
 
FIGURE 7. hiPSC line, day 39-40 of culturing. (A) adherent culturing conditions, overview. (B) 
adherent culturing conditions, close-up. (C) d40 EB-like culturing conditions, overview, (D) d40 EB-
like culturing conditions, close-up. Some of the pigmented areas are marked with arrows.
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5.2 Characterization 
 
 
5.2.1 Morphology 
 
Only hESC-RPEs that were differentiated with adherent culturing gave enough yield to be 
passaged successfully to 24-well plate and hanging culture inserts. EB-like cultured hESCs 
and adherent cultured hiPSCs were also plated to 24-well plate, but the passaged cell did not 
proliferate (data not shown.) After plating, the hESC subculture went through epithelial-
mesenchymal transition (EMT) before reforming into RPE-like pigmentated cells of cobble-
stone morphology (figure 8.) 
 
 
FIGURE 8. Plated adherent cultured hESC-RPE cells in different time points. (A) On d1 cells were 
attaching to the surface (B) on d6 cells were going through the EMT, fibroblast-like morphology (C) 
on d12 cells had proliferated and started to reach confluency (D) Cells started to form a cobblestone-
like morphology during d18 but were not yet fully confluent (E) on d23 the cells had gained conflu-
ent morphology (F) d37 RPE-like cells had gained back their original appearance. Magnification 
10x, scale bar 50 µm. 
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5.2.2 Transepithelial electric resistance of the PET-membranes 
 
Transepitheliel electric resistance was measured from the PET-membrane inserts shown in 
figure 9 to analyze the barrier properties of the cell monolayer. Control insert without cells 
was used to reduce the background produced by the PET membrane. The measured TER 
was converted to unit area resistance with the membranes surface area. Results are shown in 
table 7.  
 
 
FIGURE 9. PET-membrane cultures before TER measurements. (A) M- control (d92 on insert) (B) 
M+/M- control (d78 on insert) (C) hESC adherent induction insert (d36 on insert.) Pictures taken 
through phase contrast microscopes oculars, magnification 2,5x. No scale bar provided. 
 
 
TABLE 7 Results of the TER measurements 
Cell sample Culturing days on insert TER (Ω· cm2) 
M- control d92 420 
M+/M- control d78 115 
hESC adherent d36 2 
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5.2.3 Immunofluorescence staining 
 
The immunofluorescence stainings were performed when the adherently differentiated 
hESC-RPE cells had been 40 to 49 days on the permeable PET-membrane inserts. Despite 
poor condition of the formed epithelial monolayer, there were nevertheless decent areas to 
analyze with immunofluorescense stainings. Nuclei stainings with DAPI were observed with 
microscope, but the observations did not show in the pictures since the dark melanin pig-
mentation concealed the DAPI in the cells.  The immunostaining for CRALBP, ZO-1, Na+-
K+-ATPase and bestrophin were positive for the hESC-RPEs developed in this study. The 
stainings for the control samples were not essential for this thesis and are not therefore dis-
cussed in detail in the results.  
 
Figure 10 shows images taken from cells stained with CRALBP (A488, cyan green) and 
ZO-1 (A568, reddish orange) antibodies. Nuclei staining DAPI (cyan) cannot be recognized, 
due to the concealment by dense melanin pigmentation. The phenomena is relatively com-
mon with highly pigmented RPE-like cells. Blue dominating in the images is from back-
ground fluorescence from the PET-membrane. It should be noted that the images taken from 
the sample cover only a small area. The overview of the sample illustrated relatively high 
variation on different parts of the sample. 
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FIGURE 10. Images taken with confocal microscopy, magnification 63x (oil immersion) of 
CRALBP and ZO-1 immunostained hESC samples. Bluish/magenta color is mainly from the fluo-
rescent PET-membrane, nuclei staining DAPI is colored with cyan (A) Parts of the sample that 
demonstrated a beautiful cobblestone morphology. (B) Demonstration from the distressed parts of 
the sample.  (C) Variable cell morphology. (D) Confocal stack image that shows part of the sample 
where ZO-1 can be seen well on cell junctions and CRALPB in the cytoplasm.  
 
Images in the figure 11 are from samples that were immunostained for Na+/K+-ATPase 
(A488, cyan green) and bestrophin (A568, reddish orange.) Images are formed with confocal 
image; image in the middle is the most describing overview of the sample, and the slides on 
top and left are cross-sections formed from stack of images taken from the different depths 
of the sample.  The DAPI-stained nuclei can be seen as cyan colored with some cells on the 
area on the left image 11B.  
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FIGURE 11. Confocal stack images from immunostained hESC-RPE samples, magnification 63x 
(oil immersion.) Na+/K+-ATPase can be seen as cyan green (A488) and bestrophin as reddish orange 
(A568.) DAPI stained the cell nuclei as cyan blue. Na+/K+ is polarized on the apical cell membrane. 
A) Stratified part of the sample, image taken first batch of the hESCs, (7 weeks on inserts) B) Cells 
formed RPE-like monolayer, part found on the second batch of hESCs patches (5 weeks on inserts.) 
 
The immunocytochemical analyses of the control sample M- showed that the cells were 
stressed probably duo to cellular senescence which often occurs in prolonged cell culture. 
Beside these results, other comparable immunofluorescence stainings from cells with same 
differentiation method can be found in the research of Vaajasaari et al. 2011. Some of the 
data collected from control M+/M- can be seen in the appendix 1. Condition of the observed 
areas indicated that the cells had possibly been detached during the stainings. The results of 
the stainings were in conformity with the outcome of the sample hESC-RPE. The control 
M+/M- had two additional stainings with antibodies for RPE65 and claudin-19. These are 
included in appendix 1. Since RPE65 was almost nonexistent, the staining was concluded as 
negative. Immunostaining for claudin-19 was positive, with higher intensity on proximity of 
certain individual cells.  
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6 DISCUSSION 
 
The objective of the thesis was to further optimize a directed RPE differentiation method by 
comparing adherent and EB-like culturing methods. Differentiation of hPSCs into RPE-like 
cells was first determined by observation of melanin pigmentation development. In hESC 
line the pigmentation was detected a day apart in both adherent and EB-like cultures, but in 
the end, only adherent culture developed enough pigmented cells for subculture. With dif-
ferentiating hiPSCs, the EB-like cultures had delayed formation of pigmentation compared 
to adherent cultures. Differentiation in EB-like suspension cultures did not show improve-
ment even when cultured further from the first timepoint of around d40 (data not shown.)  
 
The adherent hESC-RPE cultures were selected and passaged successfully forward to 24-
well plates and PET-membrane inserts, and after a 40 to 49-day maturation period, analyzed 
by means of immunofluorescent stainings. Based on the results provided in this study, ad-
herent differentiation conditions may turn out to be more preferable for hPSC-RPE when the 
differentiation has been directed with induction. Also, in the native environment epithelial 
RPE monolayer grows adherently attached to Bruch’s membrane. 
 
Induction of differentiation did not seem work well for EB-like aggregates, as can be ap-
proximated from figures 6 and 7. The first pigmentation of cells in adherent hESC cultures 
(d17-d22) seemed to appear just slightly faster than in the spontaneous EB-like cultures de-
veloped for another studies in the same laboratory; these spontaneously differentiated hESC 
of the same particular cell line started to develop pigmentation on average on day 23 (the 
mean results with five different hESC passages, data not shown.)   
 
One of the two hiPSC batches yielded notably small amount of differentiated, melanin pig-
mented cells (data not shown.) The better success with the second batch indicated that the 
problem was more likely with the quantity of the cells than the quality, since in the begin-
ning of differentiation the first hiPSC batch had significally less stem cell colonies to even 
begin to differentiate. However, with these particular cell lines the hiPSCs gave poorer yield 
of RPE-like cells than the hESCs. The hiPSC-RPE cells did not live through of the subcul-
turing and therefore, there are no follow-up results for the cell line.  
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The differentiated melanin pigmented cells were characterized to identify if they resembled 
RPE-like cells. Since in the time limits of the study only the adherent differentiation for 
hESC provided sufficient yields, the quality of the hPSC-RPE cells was thus determined 
only for these cell samples. The cell seedings on the porous PET-insert did not form an epi-
thelial-like monolayer, but instead a network-like formation of stratified cells. This is not 
expected behavior with RPE-like cells, but the phenomenon has been noted also in another 
study (Rowland et al. 2013.) Despite these problems, the immunostainings turned out to be 
successful and gave informative results.   
 
TER interprets the confluence and barrier properties of a cell monolayer. Some of the refer-
ence values for RPE monolayer presented in literature can be found on table 1 on page 24. 
The TER measurements for control sample M- showed of a formation of a proper monolay-
er, while the values were slightly lower for the control M+/M-. As for the hESC-RPE sam-
ple, it can be seen from measured TER values and even from figure 9 on page 40, that the 
cells produced in this study did not form a monolayer that could have had any kind of barrier 
properties. However, regarding the immunofluorescence stainings, the quality of the hESC-
RPE cells was still relatively good. 
 
The immunofluorescence staining provided information about how the cell expressed known 
markers for RPE-like cells. The existence and location of the RPE markers depicted the ma-
turity and development of the RPE-like cells. The sample cells that were differentiated with 
induction method were rather matured, despite their short differentiation and culturing peri-
od (Carr et al. 2014.)  Early maturation could have been resulted with the induction used in 
the beginning of the differentiation process. 
 
RPE marker protein CRALBP was found in the cytoplasm and in close proximate of cell 
membrane (10D, confocal image.) The faintly showing junction protein ZO-1 was found 
mainly in the nucleus of the cells. In some parts of the sample, ZO-1 could be also seen in 
the cell-cell junctions suggesting formation of tight junctions. ZO-1 was positive on all over 
the sample, but higher intensity of fluorescence could be observed between some certain 
cells shown outside of the area in figure 10.  The cells show a cobblestone-like morphology. 
Some stretching of the cells can be seen on images 10B and 10C. Most of the images were 
taken from the prominent parts of the sample that formed epithelial-like monolayer. 
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In confocal stacks on figure 11A and 11B, Na+/K+-ATPase was located on the apical side of 
the cells membrane. Normally bestrophin should be found on the basal membrane on ma-
tured RPE-cells. However, as seen more properly on the image 11B, bestrophin can also be 
found elsewhere, in nucleus and cytoplasm, when the cells are still relatively unmatured. 
Morphology of the cells is relatively good, but the undesirable formation of stratification can 
be seen especially on figure 11A. 
 
The cell monolayer was relatively well formed in the control culture M+/M-, but after the 
immunostainings, microscope-examination revealed that the monolayer was destroyed on 
some areas and cells were detached from most parts of the membrane.  This suggests that the 
cell were not attached properly to the basal membrane during the culturing period. The same 
phenomena could have appeared in the hESC-RPE sample in the formation of the stratified, 
network-like growth. 
 
Reasons for the problematic development of the cell monolayer could be caused by many 
different variables. One difference between the hESC-RPE sample and M+/M- control was 
that the sample cells were plated straight from the differentiation stage. Thus, the sample 
hESC-RPE cells did not have opportunity to form a subculture of homogenous colonies, 
which could have yielded purer RPE-like populations (Vaajasaari et al. 2011.)  More likely, 
the problems could be with the insert culturing on a PET-membrane, since the seeding to 24-
well plate turned out fine as can be seen on figure 8 on page 39.  
 
The control culture M- with spontaneous induction developed the finest monolayer of the 
characterized cells, which proposes influence of the executed induction.  It should also be 
noted that in the time of the study, collagen IV coatings gave varied development of mono-
layer in other cell cultures developed in the laboratory (data not shown.) It has been shown 
that the coating substance has an impact in the formation of the confluent monolayer (Row-
land et al. 2013.)  
 
In conclusion, the results found in this study suggested that TER is not by itself a reliable 
measurement of the development state of the RPE-like cells.  Immunostainings revealed that 
the cells were polarized resembling RPE cells by expressing the specific molecular markers.  
The marker proteins were not in all cases yet located where they are normally expressed in 
mature native RPE-cells.  
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The results provided in this study suggest that for specific type of directed differentiation of 
hPSCs into RPE, the adherent culture method gives significantly better yield than the EB-
like culture method. The induction seems to work with both hESCs and iPSCs, but the yield 
tends to differ.  It has been shown in other studies that iPSCs and hESCs show variability in 
their propensity to generate viable RPE cells (Buchholz et al. 2009; Rowland et al. 2013; 
Vaajasaari et al. 2011). 
 
To determine if this culturing method combined with directed differentiation could be prom-
ising way to derive hPSC-RPE cells, further research is needed on the subject with different 
cell lines and bigger cell amounts to compare more closely on the yields and efficiency with 
the spontaneous culturing method. Results from the immunostainings suggest that the differ-
entiation method used in this provided RPE-like cells that were yet completely mature in the 
given time, but promisingly well developed. Functionality of the RPE-like cells could be 
shown with for example by testing the cell’s ability of phagocytosis of POS.  
 
The problems with monolayer development on inserts and thus effects in the TER values 
suggest a problem in the attachment of the cells on the surface. The main causes of this 
could possibly be the coating of the surfaces by collagen IV, the quality of PET-membranes 
or the passage of the differentiated cells. It is necessary to determinate the main source of 
problematic formation of monolayer for the development of cell cultures in the future. It 
should be kept in mind that hPSCs and their differentiation are very delicate biological pro-
cesses, and even minor variables, such as subtle changes in culturing media or basal mem-
brane, could possibly affect in drastic measurements.  
Research aims were achieved to the extent that there were found notable difference in the 
yield between the cell culturing methods. Based on the immunostaining results, adherent 
culturing method with directed differentiation produced RPE-like cells in relatively short 
time period and could be a promising new method to develop RPE-cells for future applica-
tions. 
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APPENDICES 
Appendix 1. M+/M- control cell culture immunostainings 
 
 
FIGURE 12 Control cell culture M+/M- immunostainings. A) Na+/K+-ATPase A488, B) RPE65 
A488 (negative), ZO-1 A568 C) CRALBP A488  D) Claudin 19 A488. Confocal microscope, 63x oil 
immersion. 
 
